scholarly article | Q13442814 |
P2093 | author name string | Chang Woo Han | |
Myeong Ho Jung | |||
Han-Sol Jeong | |||
Ki-Tae Ha | |||
Min-Kyung Jang | |||
Byung Joo Kim | |||
Jeong Soo Nam | |||
Yu-Ran Han | |||
P2860 | cites work | Sickle cell anemia, a molecular disease | Q7507635 |
Case-control cohort study of patients' perceptions of disability in mastocytosis | Q21092209 | ||
Role for protease activity in visceral pain in irritable bowel syndrome | Q22241892 | ||
Manual therapies for migraine: a systematic review | Q24622838 | ||
The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis | Q24676988 | ||
The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling | Q27008029 | ||
Possible pathophysiology of ketamine-related cystitis and associated treatment strategies | Q27013111 | ||
ASICs as therapeutic targets for migraine | Q27013569 | ||
Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis | Q58228805 | ||
Simultaneous monitoring of endothelin-1 and vasopressin plasma levels in migraine | Q59264489 | ||
Effects of alismol isolated from Alismatis Rhizoma on calcium-induced contraction in the rabbit thoracic aorta | Q69405311 | ||
In vitro inducible nitric oxide synthesis inhibitors from Alismatis Rhizoma | Q73152738 | ||
A new triterpenoid from Alisma orientale and their antibacterial effect | Q85613507 | ||
Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease | Q95825369 | ||
Fatal overdose due to prescription fentanyl patches in a patient with sickle cell/beta-thalassemia and acute chest syndrome: A case report and review of the literature | Q37494147 | ||
Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis | Q37496549 | ||
Endoplasmic reticulum stress in beta-cells and development of diabetes | Q37576455 | ||
Nociceptive and inflammatory mediator upregulation in a mouse model of chronic prostatitis. | Q37603370 | ||
Mast cells: target and source of neuropeptides | Q37622378 | ||
Significance of Conversation between Mast Cells and Nerves | Q37763299 | ||
Mast cells in allergic and inflammatory diseases | Q37990583 | ||
Mast cells: an expanding pathophysiological role from allergy to other disorders | Q38007884 | ||
Mast cells: a new target in the treatment of complex regional pain syndrome? | Q38089303 | ||
A focus on mast cells and pain | Q38152516 | ||
Mast cells in chronic inflammation, pelvic pain and depression in women | Q38210386 | ||
Traditional uses, phytochemistry, pharmacology, toxicology and quality control of Alisma orientale (Sam.) Juzep: a review. | Q38275021 | ||
Cross talk between ER stress, oxidative stress, and inflammation in health and disease | Q38389425 | ||
Skin and self-injury: a possible link between peripheral innervation and immune function? | Q38390264 | ||
Menstruation pulls the trigger for inflammation and pain in endometriosis | Q38433720 | ||
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome | Q38912595 | ||
Autonomic nerve development contributes to prostate cancer progression | Q39126984 | ||
Critical role of protease-activated receptor 2 activation by mast cell tryptase in the development of postoperative pain | Q39236007 | ||
Involvement of mast cells in a mouse model of postoperative pain | Q39257584 | ||
Urinary histamine excretion in migraine and cluster headache. Further observations | Q39462146 | ||
Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis | Q39689627 | ||
Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice | Q39733882 | ||
Endogenous μ-opioid peptides modulate immune response towards malignant melanoma | Q39826592 | ||
Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder | Q40091176 | ||
RANTES mediates TNF-dependent lamina propria mast cell accumulation and barrier dysfunction in neurogenic cystitis | Q40179873 | ||
A new triterpene and anti-hepatitis B virus active compounds from Alisma orientalis | Q40252794 | ||
Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor | Q40412140 | ||
Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice | Q40620939 | ||
Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation | Q40708272 | ||
Mast cells infiltration and decreased E-cadherin expression in ketamine-induced cystitis | Q41680745 | ||
Plasticity of dorsal root ganglion neurons in a rat model of post-infectious gut dysfunction: potential implication of nerve growth factor. | Q41725150 | ||
Mast cell: an emerging partner in immune interaction | Q41862702 | ||
Measuring changes in tactile sensitivity in the hind paw of mice using an electronic von Frey apparatus. | Q42151246 | ||
Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators | Q42382574 | ||
Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer | Q42444701 | ||
Mast cell activation contributes to sickle cell pathobiology and pain in mice | Q42612548 | ||
Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects | Q42908309 | ||
Histologic and receptor analysis of primary and secondary vestibulodynia and controls: a prospective study | Q43079748 | ||
Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients | Q43080831 | ||
Hyperinnervation in intestinal deep infiltrating endometriosis | Q43246615 | ||
Anti-inflammatory activities and effect of rhizoma Alismatis on immune system | Q43917120 | ||
Whole blood and plasma histamine in common migraine | Q43989954 | ||
Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases | Q27027733 | ||
Mast cell-derived histamine mediates cystitis pain | Q27301376 | ||
Signal integration in the endoplasmic reticulum unfolded protein response | Q27860577 | ||
Morphine for the treatment of pain in sickle cell disease | Q28087296 | ||
The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome | Q28288581 | ||
Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers | Q28376497 | ||
PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation | Q28507769 | ||
Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome | Q28568698 | ||
The unfolded protein response: from stress pathway to homeostatic regulation | Q29547396 | ||
Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes | Q29615503 | ||
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee | Q29618782 | ||
Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis | Q30883753 | ||
Buthus martensi Karsch agonist of skeletal-muscle RyR-1, a scorpion active polypeptide: antinociceptive effect on rat peripheral nervous system and spinal cord, and inhibition of voltage-gated Na(+) currents in dorsal root ganglion neurons | Q31719572 | ||
Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies | Q33215661 | ||
Fibromyalgia: a stress disorder? Piecing the biopsychosocial puzzle together | Q33340274 | ||
Self-injurious behavior in neurodevelopmental disorders: relevance of nociceptive and immune mechanisms | Q33350466 | ||
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome | Q33481455 | ||
Activation of cutaneous immune responses in complex regional pain syndrome | Q33573783 | ||
Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones | Q33852512 | ||
Tryptase-PAR2 axis in experimental autoimmune prostatitis, a model for chronic pelvic pain syndrome | Q33872709 | ||
Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma | Q33872716 | ||
Pathological pain and the neuroimmune interface | Q33925677 | ||
Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer | Q33951506 | ||
Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations | Q34100104 | ||
Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment | Q34140944 | ||
Mast cells: versatile gatekeepers of pain | Q34225889 | ||
The rhizomes of Alisma orientale and alisol derivatives inhibit allergic response and experimental atopic dermatitis | Q34299604 | ||
Aromatase and endometriosis | Q34313406 | ||
Dural afferents express acid-sensing ion channels: A role for decreased meningeal pH in migraine headache | Q34419829 | ||
Mast cell activation syndrome as a significant comorbidity in sickle cell disease | Q34564293 | ||
Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome | Q34606239 | ||
Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. | Q34649530 | ||
Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis | Q34654055 | ||
The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions | Q44177600 | ||
c-Fos expression in rat spinal cord induced by scorpion BmK venom via plantar subcutaneous injection | Q44225254 | ||
Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer | Q44347717 | ||
Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea | Q44652662 | ||
Induction of the neurokinin 1 receptor by TNFα in endometriotic tissue provides the potential for neurogenic control over endometriotic lesion growth. | Q44655837 | ||
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. | Q44779671 | ||
Role of immunoreactions and mast cells in pathogenesis of human endometriosis--morphologic study and gene expression analysis | Q44789361 | ||
Prophylactic treatment of pediatric migraine | Q44794041 | ||
Mast cells are involved in inflammatory reactions during Complex Regional Pain Syndrome type 1. | Q44798721 | ||
Light and electron microscopic evaluation of antileukotriene therapy for experimental rat endometriosis | Q44799160 | ||
Melatonin improves bladder symptoms and may ameliorate bladder damage via increasing HO-1 in rats | Q44847432 | ||
Localization of mast cells in endometrial cysts | Q44948407 | ||
Evidence for a vascular factor in migraine | Q45024230 | ||
Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin | Q45114651 | ||
Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor | Q45200756 | ||
Unilateral spinal nerve ligation leads to an asymmetrical distribution of mast cells in the thalamus of female but not male mice | Q45284273 | ||
How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage). | Q45338327 | ||
Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome | Q45823431 | ||
Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. | Q45971212 | ||
Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. | Q46036918 | ||
Relationship between Toll-like receptor-4 and mPGES-1 gene expression in local lesions of endometriosis patients. | Q46254401 | ||
High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia | Q46555325 | ||
Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis | Q46695184 | ||
Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity | Q46808316 | ||
CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury | Q46823993 | ||
Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally | Q46955595 | ||
Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury | Q47185912 | ||
Degranulated mast cells in the skin of adults with self-injurious behavior and neurodevelopmental disorders | Q47296214 | ||
Open-label trial of cinnarizine in migraine prophylaxis | Q47874851 | ||
Suppression by intrathecal BmK IT2 on rat spontaneous pain behaviors and spinal c-Fos expression induced by formalin | Q48139313 | ||
The pharmacotherapy of chronic pain | Q48428832 | ||
Antihyperalgesia effect of BmK AS, a scorpion toxin, in rat by intraplantar injection | Q48470473 | ||
Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators | Q48599973 | ||
The anti-nociceptive effect of BmK AS, a scorpion active polypeptide, and the possible mechanism on specifically modulating voltage-gated Na+ currents in primary afferent neurons | Q48696331 | ||
Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients | Q48771497 | ||
The modulation effects of BmK I, an alpha-like scorpion neurotoxin, on voltage-gated Na(+) currents in rat dorsal root ganglion neurons | Q48789294 | ||
Suppressive effects of BmK IT2 on nociceptive behavior and c-Fos expression in spinal cord induced by formalin | Q48952470 | ||
Antihyperalgesia effect of BmK IT2, a depressant insect-selective scorpion toxin in rat by peripheral administration | Q49159113 | ||
Activated Mast Cells Infiltrate in Close Proximity to Enteric Nerves in Diarrhea-predominant Irritable Bowel Syndrome | Q34658883 | ||
Summation model of pelvic pain in interstitial cystitis | Q34820741 | ||
Interstitial cystitis: an unsolved enigma | Q35006808 | ||
Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer | Q35011905 | ||
Contact hypersensitivity to oxazolone provokes vulvar mechanical hyperalgesia in mice | Q35036636 | ||
Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. | Q35039931 | ||
Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model | Q35115759 | ||
Mast Cell-dependent Mesenteric Afferent Activation by Mucosal Supernatant From Different Bowel Segments of Guinea Pigs With Post-infectious Irritable Bowel Syndrome. | Q35430640 | ||
Mast cell and autoimmune diseases | Q35470932 | ||
Mast Cell Stabilizer (Ketotifen) in Fibromyalgia: Phase 1 Randomized Controlled Clinical Trial | Q35563612 | ||
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal | Q35574171 | ||
Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). | Q35742243 | ||
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. | Q35761348 | ||
Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome | Q35850819 | ||
Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model. | Q35907138 | ||
Mast cells as targets of corticotropin-releasing factor and related peptides | Q35921656 | ||
Endoplasmic reticulum stress in liver disease | Q36031838 | ||
Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions | Q36082146 | ||
Mast cell degranulation activates a pain pathway underlying migraine headache | Q36098310 | ||
Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response | Q36131259 | ||
Chronic psychological stress enhances nociceptive processing in the urinary bladder in high-anxiety rats | Q36156364 | ||
Peripheral Innervation in Children With Global Developmental Delay: Biomarker for Risk for Self-Injurious Behavior? | Q36176914 | ||
Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents | Q36183590 | ||
Ca(2+)/calmodulin-dependent protein kinase II is associated with pelvic pain of neurogenic cystitis. | Q36208864 | ||
MCP-1-induced histamine release from mast cells is associated with development of interstitial cystitis/bladder pain syndrome in rat models | Q36282765 | ||
CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis | Q36309229 | ||
Nonalcoholic fatty liver disease: from steatosis to cirrhosis | Q36382279 | ||
Biology of mast cell tryptase. An inflammatory mediator | Q36460904 | ||
Evidence of altered epidermal nerve fiber morphology in adults with self-injurious behavior and neurodevelopmental disorders | Q36497628 | ||
Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment | Q36518248 | ||
Inflammation in complex regional pain syndrome: a systematic review and meta-analysis | Q36659427 | ||
Prevalence of pain in patients with cancer: a systematic review of the past 40 years | Q36758835 | ||
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. | Q36771308 | ||
Modulation of meningeal nociceptors mechanosensitivity by peripheral proteinase-activated receptor-2: the role of mast cells | Q36824391 | ||
TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I | Q36862101 | ||
Role of mast cells in male chronic pelvic pain | Q36869672 | ||
Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. | Q36881864 | ||
Local action of the proinflammatory cytokines IL-1β and IL-6 on intracranial meningeal nociceptors | Q36908493 | ||
Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain | Q36930795 | ||
Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx | Q37015361 | ||
Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome | Q37037977 | ||
Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation | Q37143569 | ||
Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome | Q37169930 | ||
pH-evoked dural afferent signaling is mediated by ASIC3 and is sensitized by mast cell mediators | Q37170692 | ||
Immune mediators of chronic pelvic pain syndrome | Q37179457 | ||
Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. | Q37253305 | ||
Targeting nerve growth factor in pain: what is the therapeutic potential? | Q37322267 | ||
The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome | Q37345168 | ||
Self-injurious behavior: A clinical appraisal | Q37370394 | ||
The role of the lipogenic pathway in the development of hepatic steatosis. | Q37386081 | ||
Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome | Q37390132 | ||
Allergic reactions and risk of vulvodynia | Q37413078 | ||
Localization of COX-1 and COX-2 in the intracranial dura mater of the rat. | Q37417107 | ||
Subtypes of bladder mast cells in interstitial cystitis. | Q50509596 | ||
Mast cells mediate the severity of experimental cystitis in mice. | Q50518150 | ||
Mast cells in accessory glands of experimentally induced prostatitis in male Wistar rats. | Q50763419 | ||
The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain. | Q50871091 | ||
The inhibitory effects of BmK IT2, a scorpion neurotoxin on rat nociceptive flexion reflex and a possible mechanism for modulating voltage-gated Na(+) channels. | Q51367410 | ||
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. | Q52461216 | ||
Purification, cDNA cloning and function assessment of BmK abT, a unique component from the Old World scorpion species. | Q52582430 | ||
An increase in serum tryptase even below 11.4 ng/mL may indicate a mast cell-mediated hypersensitivity reaction: a prospective study in Hymenoptera venom allergic patients. | Q52730847 | ||
Mast cells in endometriosis: guilty or innocent bystanders? | Q52889665 | ||
Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. | Q53622343 | ||
Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia. | Q54104085 | ||
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS. | Q54491760 | ||
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. | Q54513905 | ||
Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. | Q54573883 | ||
Chronic myeloid leukaemia and sickle cell disease: could imatinib prevent vaso-occlusive crisis? | Q54596868 | ||
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome | Q56985161 | ||
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome | Q56996391 | ||
TRPV1 expression on peritoneal endometriosis foci is associated with chronic pelvic pain | Q57099194 | ||
Systemic mastocytosis and bone involvement in a cohort of 75 patients | Q57217806 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endoplasmic reticulum | Q79927 |
steatosis | Q1365091 | ||
P304 | page(s) | 26151-26165 | |
P577 | publication date | 2015-11-02 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | Protective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress | |
P478 | volume | 16 |
Q92832876 | Comparative transcriptome and metabolite profiling of four tissues from Alisma orientale (Sam.) Juzep reveals its inflorescence developmental and medicinal characteristics |
Q96137783 | Herbal formulation MIT ameliorates high-fat diet-induced non-alcoholic fatty liver disease |
Q57213089 | Inhibitory Effect of Ethanolic Extract on NF-κB-Dependent CXCR3 and CXCL10 Expression in TNFα-Exposed MDA-MB-231 Breast Cancer Cells |
Q91620634 | Methyl jasmonate promote protostane triterpenes accumulation by up-regulating the expression of squalene epoxidases in Alisma orientale |
Q91639783 | Pharmacological Activities of Alisma orientale against Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: Literature Review |
Q38811934 | Targeting endoplasmic reticulum stress in liver disease. |
Q37410782 | The Cholesterol-Lowering Effect of Alisol Acetates Based on HMG-CoA Reductase and Its Molecular Mechanism. |
Q53211469 | The Protective Effects of Alisol A 24-Acetate from Alisma canaliculatum on Ovariectomy Induced Bone Loss in Vivo. |
Q39405127 | Therapeutic potential of Rhizoma Alismatis: a review on ethnomedicinal application, phytochemistry, pharmacology, and toxicology. |
Q95277081 | Triterpenoids From Alisma Species: Phytochemistry, Structure Modification, and Bioactivities |
Search more.